New Technology Could Deliver Drugs to Brain Injuries
Peptide carries molecules and nanoparticles to acutely damaged areas of the brain
Most traumatic brain injuries (TBIs) occur as a result of car crashes, falls and violence. The initial TBI cannot be repaired. However, scientists feel they have found a technology that can limit the damaging effects patients could potentially encounter with a TBI. “We have found a sequence of four amino acids, cysteine, alanine, glutamine and lysine (CAQK), that recognizes injured brain tissue,” said Erkki Ruoslahti, MD, PhD, distinguished in SPB’s NCI-Designated Cancer Center and senior author of the study. “This peptide could be used to deliver treatments that limit the extent of damage.” To read more, click here.
GOODMAN Oral Board Preparation Course Tumor
Nov. 1-3, 2017; Glendale, Ariz.
2017 From Cranial to Spine: An Overview of Neurosurgical Topics for the Advanced Practice Provider
Aug. 30-Sept. 2, 2017; Chicago
Mayo Clinic Neuroscience and Oncology Innovation Summit 2017
Sept. 7-9, 2017; Orlando, Fla.
63rd Annual Meeting of the Western Neurological Society
Sept. 8-11, 2017; Banff, Alberta, Canada
6th Homburger Neuroendoscopy Week
Sept. 11-15, 2017; Germany